Article Information
History
- April 15, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- James Blackstone1,
- Oliver Stirrup2,
- Fiona Mapp2,
- Monica Panca1,
- Andrew Copas2,
- Paul Flowers3,
- Leanne Hockey1,
- James Price4,
- David Partridge5,
- Christine Peters6,
- Thushan de Silva7,
- Gaia Nebbia8,
- Luke B. Snell8,
- Rachel McComish1,
- the COVID-19 Genomics UK (COG-UK) Consortium and
- Judith Breuer9,*
- 1Comprehensive Clinical Trials Unit, Institute of Clinical Trials and Methodology, UCL, London, UK
- 2Institute for Global Health, UCL, London, UK
- 3School of Psychological Sciences and Health, University of Strathclyde, Glasgow, UK
- 4Faculty of Medicine, Department of Infectious Disease, Imperial College London, UK
- 5Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
- 6Queen Elizabeth University Hospital, Greater Glasgow and Clyde Heath Board, Glasgow, UK
- 7Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, UK
- 8Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
- 9Infection, Immunity and Inflammation, Great Ormond Street Institute of Child Health, UCL, London, UK
- ↵*Corresponding Author: Prof. Judith Breuer, j.breuer{at}ucl.ac.uk, Institute of Child Health, University College London,30 Guilford Street, London, WC1N 1EH, UK
Posted April 15, 2021.
Protocol for the COG-UK hospital onset COVID-19 infection (HOCI) multicentre interventional clinical study: evaluating the efficacy of rapid genome sequencing of SARS-CoV-2 in limiting the spread of COVID-19 in United Kingdom NHS hospitals
